Experic’s Justin Lacombe, PhD, spoke on inhalation delivery trends in clinical supply services at the Inhalation & Respiratory Drug Delivery Congress on March 19th. The show drew 150 attendees from leading pharmaceutical organizations and biotech companies.
Speakers included delegates from Novartis, Genentech, Insmed, and InCarda Therapeutics, as well as academics from University of Colorado, University of New Mexico, and University of California. The Congress was a great networking opportunity for everyone who could attend the two days of educational sessions.
Justin Lacombe is the Director of Pharmaceutical Development & Manufacturing Services at Experic. For the past 12 years, he has been developing inhaled pharmaceutical products on meter dose inhalers (Catalent Pharma Solutions) and dry-powder inhalation products (Teva). Justin has managed projects for the manufacture of clinical trial materials combining small volume powder dosing technology, primary packaging development, and formulation optimization.
If you missed us in San Diego, catch up with us at one of these shows.